{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:39:47Z","timestamp":1779338387531,"version":"3.51.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bilirubin encephalopathy is a poorly recognized complication in dogs with immune-mediated hemolytic-anemia (IMHA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Assess serial trends of hyperbilirubinemia and the association between bilirubin concentrations and neurologic signs in dogs with IMHA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Eighty one dogs with non-associative IMHA and hyperbilirubinemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multicenter retrospective cohort study. The signalment, clinical signs, clinicopathological data, treatment, and outcome were evaluated. Bilirubin concentrations were recorded at the baseline, peak, initial decrease, and normalization. Univariable logistic regression was used to determine the association between neurologic signs and hyperbilirubinemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median bilirubin concentrations at the baseline, peak, and initial decrease were 2.5 (IQR, 1.4\u20134.8), 3.7 (IQR, 1.8\u201324.2), and 1.1\u00a0mg\/dL (IQR, 0.5\u20134.3; 43, 64, and 19\u00a0\u03bcmol\/L), respectively. Twenty percent (16\/81) of dogs developed neurologic signs. Neurologic signs included stupor, non-ambulatory tetraparesis, and generalized seizures. A significant association was found between the presence of neurologic signs and the baseline, peak, and fold-change of bilirubin concentration (P\u00a0&amp;lt;\u00a0.001). The odds of having neurologic signs were 12.2 (95% CI, 3.1-48.2) for dogs with baseline bilirubin concentrations \u22653.3\u00a0mg\/dL (\u226557.5\u00a0\u03bcmol\/L), and 93.3 (95% CI, 11.0-795.5) for dogs with peak bilirubin concentrations \u226513.9\u00a0mg\/dL (\u2265239.5\u00a0\u03bcmol\/L).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and clinical importance<\/jats:title>\n                    <jats:p>Although the causation of the neurologic signs cannot be attributed solely to bilirubin based on our study, these findings emphasize the importance of monitoring serum bilirubin concentrations and the development of neurologic signs in dogs with IMHA. The results reflect findings in our study population and may not be directly applicable to all dogs with IMHA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jvimsj\/aalaf034","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:02:26Z","timestamp":1768986146000},"source":"Crossref","is-referenced-by-count":1,"title":["Hyperbilirubinemia and neurologic signs in dogs with non-associative immune-mediated hemolytic anemia: 81 cases (2015\u20132024)"],"prefix":"10.1093","volume":"40","author":[{"given":"Sasha","family":"Chapman","sequence":"first","affiliation":[{"name":"Animal Referral Hospital Canberra , Internal Medicine Department, Pialligo, Australian Capital Territory , 2609,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Angles","sequence":"additional","affiliation":[{"name":"Animal Referral Hospital Canberra , Internal Medicine Department, Pialligo, Australian Capital Territory , 2609,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Griebsch","sequence":"additional","affiliation":[{"name":"Sydney School of Veterinary Science, Faculty of Science, The University of Sydney , Sydney, New South Wales 2006 ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Yu","sequence":"additional","affiliation":[{"name":"Animal Referral Hospital Canberra , Internal Medicine Department, Pialligo, Australian Capital Territory , 2609,","place":["Australia"]},{"name":"Department of Veterinary Clinical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong , Kowloon Tong, Hong Kong,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"2026020706125027200_ref1","first-page":"2448","volume-title":"Ettinger\u2019s Textbook of Veterinary Internal Medicine - eBook","author":"Ettinger","year":"2024","edition":"9th"},{"key":"2026020706125027200_ref2","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/jvim.13642","article-title":"Predicting outcome in dogs with primary immune-mediated hemolytic anemia: results of a multicenter case registry","volume":"29","author":"Goggs","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref3","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2460\/javma.2005.226.1869","article-title":"Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)","volume":"226","author":"Weinkle","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026020706125027200_ref4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1939-1676.2002.tb02378.x","article-title":"Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs","volume":"16","author":"Carr","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2460\/javma.2001.218.543","article-title":"Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999)","volume":"218","author":"Grundy","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"2026020706125027200_ref6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1751-0813.2009.00537.x","article-title":"Immune-mediated haemolytic anaemia in 110 dogs in Victoria","volume":"88","author":"McAlees","year":"2010","journal-title":"Australia Aust Vet J"},{"key":"2026020706125027200_ref7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5326\/15473317-35-5-384","article-title":"Immune-mediated hemolytic anemia: 70 cases (1988-1996)","volume":"35","author":"Reimer","year":"1999","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020706125027200_ref8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13620-024-00277-w","article-title":"Clinical presentation, outcome and prognostic factors in dogs with immune-mediated haemolytic anaemia: a retrospective single-Centre study of 104 cases in Ireland (2002-2020)","volume":"77","author":"Duclos","year":"2024","journal-title":"Ir Vet J"},{"key":"2026020706125027200_ref9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.5326\/JAAHA-MS-7371","article-title":"Relapse risk factors for immune-mediated hemolytic anemia: a retrospective study of 163 dogs","volume":"60","author":"Bannister","year":"2024","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020706125027200_ref10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1748-5827.2011.01074.x","article-title":"Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs","volume":"52","author":"Swann","year":"2011","journal-title":"J Small Anim Pract"},{"key":"2026020706125027200_ref11","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/jvim.15463","article-title":"ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs","volume":"33","author":"Swann","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/456524","article-title":"Presumptive ischemic brain infarction in a dog with Evans\u2019 syndrome","volume":"2014","author":"Giannuzzi","year":"2014","journal-title":"Case Rep Vet Med"},{"key":"2026020706125027200_ref13","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.21521\/mw.6547","article-title":"Cerebral hemorrhage in a dog with immune-mediated hemolytic anemia and concurrent thrombocytopenia \u2013 a case report","volume":"77","author":"\u00c7olako\u011flu","year":"2021","journal-title":"Med Weter"},{"key":"2026020706125027200_ref14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.5326\/JAAHA-MS-5881","article-title":"MRI findings in a dog with kernicterus","volume":"49","author":"Belz","year":"2013","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020706125027200_ref15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/vec.12876","article-title":"Successful management of acute bilirubin encephalopathy in a dog with immune-mediated hemolytic anemia using therapeutic plasma exchange","volume":"29","author":"Heffner","year":"2019","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2026020706125027200_ref16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5326\/JAAHA-MS-7430","article-title":"Resolution of canine acute bilirubin encephalopathy and immune-mediated hemolytic anemia following four plasmapheresis treatments","volume":"60","author":"Chalifoux","year":"2024","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020706125027200_ref17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/vec.12622","article-title":"The use of therapeutic plasma exchange to reduce serum bilirubin in a dog with kernicterus","volume":"27","author":"Tovar","year":"2017","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2026020706125027200_ref18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/01652176.1987.9694106","article-title":"Bilirubin metabolism in canine hepatobiliary and haemolytic disease","volume":"9","author":"Rothuizen","year":"1987","journal-title":"Vet Q"},{"key":"2026020706125027200_ref19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/sj.jp.7211157","article-title":"Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND)","volume":"25","author":"Shapiro","year":"2005","journal-title":"J Perinatol"},{"key":"2026020706125027200_ref20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2352-4642(18)30139-1","article-title":"Neonatal hyperbilirubinaemia: a global perspective","volume":"2","author":"Olusanya","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"2026020706125027200_ref21","first-page":"7","article-title":"Bilirubin induced encephalopathy","volume":"14","author":"Karimzadeh","year":"2020","journal-title":"Iran J Child Neurol"},{"key":"2026020706125027200_ref22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.braindev.2015.01.001","article-title":"Serum unbound bilirubin as a predictor for clinical kernicterus in extremely low birth weight infants at a late age in the neonatal intensive care unit","volume":"37","author":"Morioka","year":"2015","journal-title":"Brain Dev"},{"key":"2026020706125027200_ref23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jvim.15441","article-title":"ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats","volume":"33","author":"Garden","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2024.106068","article-title":"International renal interest society best practice consensus guidelines for the diagnosis and management of acute kidney injury in cats and dogs","volume":"305","author":"Segev","year":"2024","journal-title":"Vet J"},{"key":"2026020706125027200_ref25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/clinchem\/32.3.470","article-title":"Graphical comparisons of interferences in clinical chemistry instrumentation","volume":"32","author":"Glick","year":"1986","journal-title":"Clin Chem"},{"key":"2026020706125027200_ref26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/jvim.17005","article-title":"Diagnostic and predictive ability of hyperbilirubinemia severity in cats: a multicenter retrospective study","volume":"38","author":"Salord Torres","year":"2024","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref27","volume-title":"RStudio: Integrated Development Environment for R [Internet]","author":"iPosit team","year":"2023"},{"key":"2026020706125027200_ref28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jvim.12514","article-title":"Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia","volume":"29","author":"Swann","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref29","first-page":"375","article-title":"Association of Veterinary Hematology and Transfusion Medicine (AVHTM) transfusion reaction small animal consensus statement (TRACS). Part 2: prevention and monitoring","volume":"19","author":"Davidow","year":"2009","journal-title":"J Vet Emer"},{"key":"2026020706125027200_ref30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/vec.13044","article-title":"Association of veterinary hematology and transfusion medicine (AVHTM) transfusion reaction small animal consensus statement (TRACS). Part 1: definitions and clinical signs","volume":"31","author":"Davidow","year":"2021","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2026020706125027200_ref31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jvim.15983","article-title":"Accuracy of point-of-care crossmatching methods and crossmatch incompatibility in critically ill dogs","volume":"35","author":"Marshall","year":"2021","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1939-1676.2008.0060.x","article-title":"Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs","volume":"22","author":"Piek","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref33","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.neurobiolaging.2009.08.014","article-title":"Age-dependent decline of blood-brain barrier P-glycoprotein expression in the canine brain","volume":"32","author":"Pekcec","year":"2011","journal-title":"Neurobiol Aging"},{"key":"2026020706125027200_ref34","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/jvim.15836","article-title":"Application of therapeutic plasma exchange in dogs with immune-mediated thrombocytopenia","volume":"34","author":"Kopecny","year":"2020","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1476-4431.2009.00431.x","article-title":"Use of therapeutic plasmapheresis in a case of canine immune-mediated hemolytic anemia","volume":"19","author":"Crump","year":"2009","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2026020706125027200_ref36","first-page":"2351","article-title":"Efficacy of therapeutic plasma exchange (TPE) in dogs with immune-mediated hemolytic anemia: a case-controlled study","volume":"36","author":"Cowgill","year":"2022","journal-title":"ACVIM Forum Res Abstract Program JVIM"},{"key":"2026020706125027200_ref37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/jvim.16049","article-title":"Evaluation of membrane-based therapeutic plasma exchange as adjunctive treatment for immune-mediated hematologic disorders in dogs","volume":"35","author":"Francey","year":"2021","journal-title":"J Vet Intern Med"},{"key":"2026020706125027200_ref38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12917-017-1169-2","article-title":"Vector-borne and zoonotic diseases of dogs in north-west new South Wales and the northern territory, Australia","volume":"13","author":"Shapiro","year":"2017","journal-title":"BMC Vet Res"},{"key":"2026020706125027200_ref39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/VMRR.S81869","article-title":"Canine autoimmune hemolytic anemia: management challenges","volume":"7","author":"Swann","year":"2016","journal-title":"Vet Med (Auckl)"},{"key":"2026020706125027200_ref40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/vec.12530","article-title":"Retrospective evaluation of the effect of red blood cell product age on occurrence of acute transfusion-related complications in dogs: 210 cases (2010-2012)","volume":"27","author":"Maglaras","year":"2017","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2026020706125027200_ref41","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2460\/javma.2002.220.1664","article-title":"Massive transfusion in dogs: 15 cases (1997-2001)","volume":"220","author":"Jutkowitz","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"2026020706125027200_ref42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/vec.12327","article-title":"Effect of premedication and other factors on the occurrence of acute transfusion reactions in dogs","volume":"25","author":"Bruce","year":"2015","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2026020706125027200_ref43","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1111\/jvim.15879","article-title":"Bile duct obstruction associated with pancreatitis in 46 dogs","volume":"34","author":"Wilkinson","year":"2020","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalaf034\/66458556\/aalaf034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalaf034\/66458556\/aalaf034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:12:59Z","timestamp":1770462779000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/doi\/10.1093\/jvimsj\/aalaf034\/8429717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jvimsj\/aalaf034","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"aalaf034"}}